| Product Code: ETC7215060 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Cell and Gene Therapy Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Cell and Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 France Cell and Gene Therapy Market - Industry Life Cycle |
3.4 France Cell and Gene Therapy Market - Porter's Five Forces |
3.5 France Cell and Gene Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 France Cell and Gene Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 France Cell and Gene Therapy Market Revenues & Volume Share, By Delivery Mode, 2021 & 2031F |
3.8 France Cell and Gene Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 France Cell and Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in cell and gene therapy technologies in France |
4.2.2 Rising prevalence of genetic disorders and chronic diseases driving the demand for advanced therapies |
4.2.3 Supportive regulatory environment and government initiatives promoting innovation in the cell and gene therapy market in France |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy treatments limiting adoption rates |
4.3.2 Complex manufacturing processes and challenges in scaling up production for commercialization |
4.3.3 Limited awareness and understanding of cell and gene therapy among healthcare providers and patients |
5 France Cell and Gene Therapy Market Trends |
6 France Cell and Gene Therapy Market, By Types |
6.1 France Cell and Gene Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 France Cell and Gene Therapy Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 France Cell and Gene Therapy Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 France Cell and Gene Therapy Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 France Cell and Gene Therapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 France Cell and Gene Therapy Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.3 France Cell and Gene Therapy Market Revenues & Volume, By Oncology Disorder, 2021- 2031F |
6.2.4 France Cell and Gene Therapy Market Revenues & Volume, By Genetic Disorder, 2021- 2031F |
6.2.5 France Cell and Gene Therapy Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.2.6 France Cell and Gene Therapy Market Revenues & Volume, By Neurological Disorder, 2021- 2031F |
6.2.7 France Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 France Cell and Gene Therapy Market, By Delivery Mode |
6.3.1 Overview and Analysis |
6.3.2 France Cell and Gene Therapy Market Revenues & Volume, By In-Vivo, 2021- 2031F |
6.3.3 France Cell and Gene Therapy Market Revenues & Volume, By Ex-Vivo, 2021- 2031F |
6.4 France Cell and Gene Therapy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 France Cell and Gene Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 France Cell and Gene Therapy Market Revenues & Volume, By Cancer Care Centers, 2021- 2031F |
6.4.4 France Cell and Gene Therapy Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.5 France Cell and Gene Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 France Cell and Gene Therapy Market Import-Export Trade Statistics |
7.1 France Cell and Gene Therapy Market Export to Major Countries |
7.2 France Cell and Gene Therapy Market Imports from Major Countries |
8 France Cell and Gene Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted for cell and gene therapies in France |
8.2 Percentage of healthcare facilities offering cell and gene therapy treatments |
8.3 Investment in infrastructure and facilities for cell and gene therapy manufacturing |
8.4 Patient outcomes and success rates of cell and gene therapy treatments |
8.5 Adoption rate of cell and gene therapy treatments in France |
9 France Cell and Gene Therapy Market - Opportunity Assessment |
9.1 France Cell and Gene Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 France Cell and Gene Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 France Cell and Gene Therapy Market Opportunity Assessment, By Delivery Mode, 2021 & 2031F |
9.4 France Cell and Gene Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 France Cell and Gene Therapy Market - Competitive Landscape |
10.1 France Cell and Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 France Cell and Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here